[ 35 ] reported that in patients treated with NACRT followed by surgery, there was a significant increase in pulmonary complications for 3D-CRT (odds ratio [OR], 9.13; 95% CI, 1.83–45.42) and an increasing trend for IMRT (OR, 2.23; 95% CI, 0.86–5.76) compared to that for proton therapy.
← all excerpts
The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
1
—
—